IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools - PubMed (original) (raw)

IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools

P Hainaut et al. Nucleic Acids Res. 1998.

Abstract

Since 1989, about 570 different p53 mutations have been identified in more than 8000 human cancers. A database of these mutations was initiated by M. Hollstein and C. C. Harris in 1990. This database originally consisted of a list of somatic point mutations in the p 53 gene of human tumors and cell lines, compiled from the published literature and made available in a standard electronic form. The database is maintained at the International Agency for Research on Cancer (IARC) and updated versions are released twice a year (January and July). The current version (July 1997) contains records on 6800 published mutations and will surpass the 8000 mark in the January 1998 release. The database now contains information on somatic and germline mutations in a new format to facilitate data retrieval. In addition, new tools are constructed to improve data analysis, such as a Mutation Viewer Java applet developed at the European Bioinformatics Institute (EBI) to visualise the location and impact of mutations on p53 protein structure. The database is available in different electronic formats at IARC (http://www.iarc. fr/p53/homepage.htm ) or from the EBI server (http://www.ebi.ac.uk ). The IARC p53 website also provides reports on database analysis and links with other p53 sites as well as with related databases. In this report, we describe the criteria for inclusion of data, the revised format and the new visualisation tools. We also briefly discuss the relevance of p 53 mutations to clinical and biological questions.

PubMed Disclaimer

Similar articles

• Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects.
  Hainaut P, Soussi T, Shomer B, Hollstein M, Greenblatt M, Hovig E, Harris CC, Montesano R. Hainaut P, et al. Nucleic Acids Res. 1997 Jan 1;25(1):151-7. doi: 10.1093/nar/25.1.151. Nucleic Acids Res. 1997. PMID: 9016527 Free PMC article.
• Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation.
  Hollstein M, Shomer B, Greenblatt M, Soussi T, Hovig E, Montesano R, Harris CC. Hollstein M, et al. Nucleic Acids Res. 1996 Jan 1;24(1):141-6. doi: 10.1093/nar/24.1.141. Nucleic Acids Res. 1996. PMID: 8594564 Free PMC article.
• IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines. International Agency for Research on Cancer.
  Hernandez-Boussard T, Rodriguez-Tome P, Montesano R, Hainaut P. Hernandez-Boussard T, et al. Hum Mutat. 1999;14(1):1-8. doi: 10.1002/(SICI)1098-1004(1999)14:1<1::AID-HUMU1>3.0.CO;2-H. Hum Mutat. 1999. PMID: 10447253 Review.
• New approaches to understanding p53 gene tumor mutation spectra.
  Hollstein M, Hergenhahn M, Yang Q, Bartsch H, Wang ZQ, Hainaut P. Hollstein M, et al. Mutat Res. 1999 Dec 17;431(2):199-209. doi: 10.1016/s0027-5107(99)00162-1. Mutat Res. 1999. PMID: 10635987 Review.
• Database of p53 gene somatic mutations in human tumors and cell lines.
  Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sørlie T, Hovig E, Smith-Sørensen B, Montesano R, Harris CC. Hollstein M, et al. Nucleic Acids Res. 1994 Sep;22(17):3551-5. Nucleic Acids Res. 1994. PMID: 7937055 Free PMC article.

Cited by

• The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans.
  Pant V, Quintás-Cardama A, Lozano G. Pant V, et al. Blood. 2012 Dec 20;120(26):5118-27. doi: 10.1182/blood-2012-05-356014. Epub 2012 Sep 27. Blood. 2012. PMID: 23018641 Free PMC article. Review.
• The p53 gene in patients under the age of 40 with gastric cancer: mutation rates are low but are associated with a cardiac location.
  Rugge M, Shiao YH, Busatto G, Cassaro M, Strobbe C, Russo VM, Leo G, Parenti AR, Scapinello A, Arslan P, Egarter-Vigl E. Rugge M, et al. Mol Pathol. 2000 Aug;53(4):207-10. doi: 10.1136/mp.53.4.207. Mol Pathol. 2000. PMID: 11040944 Free PMC article.
• Selective loss of codon 72 proline p53 and frequent mutational inactivation of the retained arginine allele in colorectal cancer.
  Schneider-Stock R, Boltze C, Peters B, Szibor R, Landt O, Meyer F, Roessner A. Schneider-Stock R, et al. Neoplasia. 2004 Sep-Oct;6(5):529-35. doi: 10.1593/neo.04178. Neoplasia. 2004. PMID: 15548361 Free PMC article.
• Identification of p53 and its isoforms in human breast carcinoma cells.
  Milićević Z, Bajić V, Živković L, Kasapović J, Andjelković U, Spremo-Potparević B. Milićević Z, et al. ScientificWorldJournal. 2014 Jan 5;2014:618698. doi: 10.1155/2014/618698. eCollection 2014. ScientificWorldJournal. 2014. PMID: 24511294 Free PMC article.
• iASPP is over-expressed in human non-small cell lung cancer and regulates the proliferation of lung cancer cells through a p53 associated pathway.
  Chen J, Xie F, Zhang L, Jiang WG. Chen J, et al. BMC Cancer. 2010 Dec 30;10:694. doi: 10.1186/1471-2407-10-694. BMC Cancer. 2010. PMID: 21192816 Free PMC article.

References

1. 1. Comput Appl Biosci. 1993 Feb;9(1):49-57 - PubMed
2. 1. Annu Rev Med. 1996;47:285-301 - PubMed
3. 1. Science. 1994 Jul 15;265(5170):346-55 - PubMed
4. 1. EMBO J. 1994 Aug 1;13(15):3496-504 - PubMed
5. 1. Cancer Res. 1994 Sep 15;54(18):4855-78 - PubMed

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal